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Abstract Selenoneine is the major selenium compound in fish
muscles, and fish appears to be an important source of
selenium in the fish-eating population. Selenoneine has strong
antioxidant activity and a detoxifying function against
methylmercury (MeHg) toxicity. Dietary intake, bioaccu-
mulation, and metabolism of selenoneine have not been
characterized in humans. A nutritional survey was conducted
in remote islands of the Kagoshima Prefecture in Japan. To
evaluate the potential risks and benefits of fish consumption for
health, we measured concentrations of selenoneine, total
selenium,MeHg, inorganic mercury, and polyunsaturated fatty
acid (LC-PUFA) in the blood of a fish-eating human
population. The erythrocyte, leukocyte, and platelet residues
following removal of serum (cellular fraction) contained
0.510 μg Se/g, 0.212 μg selenoneine Se/g, and 0.262 μg Se-
containing proteins Se/g, whereas the serum contained
0.174 μg total Se/g. Selenoneine was highly concentrated in
the cellular fraction in a manner that was dependent on
subjects' frequency of fish consumption. Concentrations of
selenoneine were closely correlated with concentrations of
MeHg in the cellular fraction. Selenoneine is the major
chemical form of selenium in the blood cells of this fish-
eating human population and may be an important biomarker
for selenium redox status.
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Introduction
Ocean fish, such as tuna, mackerel, and swordfish, possess a
novel selenium-containing imidazole compound, selenoneine,
which is the predominant form of organic selenium in tuna
[1–3]. This compound has a unique selenoketone structure
and is a powerful antioxidant [1–3]. The concentration of
selenium in the red blood cells (RBCs) was correlated with
the intake of selenium from animal foods and seafood,
whereas the concentration of selenium in the serum or plasma
was correlated with the intake of selenium from plant foods [4,
5]. Thus, a significant amount of selenoneine is thought to be
incorporated through the consumption of seafood. Several
studies have examined the bioavailability of selenium from
fish and other food sources [6–13].
Fish consumption is also associated with the intake of
methylmercury (MeHg) [14–21], which may cause adverse
health effects. Concentrations of nutrients, including long
chain polyunsaturated fatty acids (LC-PUFA) and specific
chemical contaminants, such as MeHg and dioxins, have been
characterized in a range of fish species [22, 23]. In addition,
the health and nutritional benefits of fish consumption have
been compared to the health risks associated with
contaminants present in fish [22, 23]. Because selenium reacts
with and detoxifies MeHg, its distribution in seafood and the
detoxifying functions of dietary selenium from seafood should
be characterized. The contents of selenoneine and total
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selenium in fish are correlated with the content of total
mercury [3]. The Se/Hg molar ratio in fish was estimated to
be 3:1 and it varied among species, ranging from 1 to 217 [3].
Such ratios may be important for estimating the MeHg risks
associated with fish consumption. Animal trials of feeding
with both MeHg [0.5 or 50 μmol/kg in diet] and sodium
selenite showed that the toxicity of MeHg decreased with
selenium intake for Se/Hg molar ratios of >0.2 [17, 18].
Selenoneine accelerated the excretion and demethylation of
MeHg through the formation of secretory extracellular
lysosomal vesicles via the specific organic cation/carnitine
transporter-1 (OCTN1) [21]. Thus, the molar Se/Hg range of
1 to 217 found in the muscle of fish is considered to represent
the normal physiological state in terms of MeHg
bioaccumulation and metabolism [3]. Therefore, animal
studies and human trials should examine various Se/Hg molar
ratios and use them to compare the physiological and
nutritional effects of fish consumption.
Here, we report the determination of selenoneine
concentrations in human blood. Significant amounts of
selenoneine accumulated in the cellular fraction, but not in
the serum, of the fish-eating Japanese population were studied
here. Concentrations of selenoneine and total selenium in the
cellular fraction might be used as an important biomarker for
fish consumption and selenium antioxidant functions.
Materials and Methods
Subjects A nutritional interview survey with medical checkup
was conducted among rural residents living on remote islands
in the Southwestern Islands in Kagoshima Prefecture, Japan,
in 2009. A total of 217 persons from four islands participated
in this study. Of the 217 persons, 50 were excluded because of
missing forms or insufficient blood samples for chemical
analysis. A total of 167 persons were covered in this study,
comprising 75 males and 92 females, all over 20 years of age.
Their mean ages were 63.2 years in both sexes. Information
was collected regarding the frequency of consumption of
seafood per week and the amounts of fish meat per meal.
The study was approved by the Ethics Committee of the
Kagoshima University Graduate School of Medical and
Dental Sciences, and informed written consent was obtained
from participants.
Fish Intake A food-frequency questionnaire was used to
assess the average intake of fish meals including shrimp, crab,
squid, octopus, and clam during the previous week.
Participants were asked to indicate their usual rate of
consumption choosing from six frequency categories. The
categories range from “never or less than once/week” to
“more than nine times per week”. The servings are specified
in terms of units or common portions (e.g., one slice of fish
fillet). An average portion size was assigned to each
questionnaire item. The subjects were divided into six
categories consuming fish meal: less than once per week =
f-time 0, once per week = f-time 1, two or three times per week
(less than once per 2 days) = f-time 2, three or four times per
week (once per 2 days) = f-time 3, everyday (five to eight
times per week) = f-time 4, every time (more than nine times
per week) = f-time 5, and categories of the amount of fish
meat: 25 g per meal = f-mass 1, 50 g per meal = f-mass 2, 75–
100 g per meal = f-mass 3, 150 g per meal = f-mass 4, 200 g or
more per meal = f-mass 5.
Chemical Analysis of the Blood Samples Blood samples were
obtained from the subjects, and the cellular fraction and serum
of a collected blood sample were separated with blood serum
separation tubes by centrifugation at 2,000×g for 10 min. The
cellular fraction and serum specimens were stored at −80 °C
until use. Concentrations ofMeHg and LC-PUFA in the blood
were previously shown to be correlated with fish consumption
[22–25]. Hence, we also analyzed whether the concentrations
of selenium and selenoneine in the cellular fraction were
correlated with the levels of MeHg and LC-PUFA.
Each sample (0.1 g) was placed in glass test tube and
digested at 200–220 °C in 1 mL of a 1:2 mixture of nitric acid
and perchloric acid and subjected to a fluorometric assay
using 2,3-diaminonaphthalene, as described previously [3,
26]. Detection limit was 0.006 μg/g. For selenium speciation
analysis, selenium compounds were detected through online
liquid chromatography–inductively coupled plasma mass
spectrometry (LC-ICP-MS) using an ELAN DRC II mass
spectrometer (PerkinElmer,Waltham,MA) [1, 3]. The cellular
fraction (20 mg) was placed in a 1.5-mL microcentrifuge tube
and homogenized in 10 volumes of ultrapure water using a
Pellet Mixer Pestle (Treff, Degersheim, Switzerland). After
centrifugation at 10,000×g for 5 min, the supernatant of
cellular fraction was used for the analysis. Each sample
(20 μL) of the cellular fraction supernatant and serum was
analyzed using an Ultrahydrogel 120 gel permeation
chromatography column (7.8×250 mm; Nihon Waters,
Tokyo, Japan) equilibrated with 0.1 M ammonium acetate
buffer containing 0.1 % (w /v ) Igepal CA-630 (Sigma-
Aldrich Japan, Tokyo, Japan), as described previously [1, 3].
During separation, selenoneine were eluted with retention
times of 10.1 min, and Se-containing proteins including
glutathione peroxidase (GPx), selenoprotein P, and other Se-
containing proteins were eluted in the void volume of the GPC
column at 5.4 min. The concentration of selenium was
determined using bovine GPx1 (Sigma-Aldrich) as a standard
of Se-containing proteins and bluefin tuna blood selenoneine.
Detection limit was 0.002 μg/g.
Concentrations of total mercury in the cellular fraction and
serum specimens were determined using flameless atomic
absorption spectrometry at 253.7 nm using an HG-310
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mercury analyzer (Hiranuma, Tokyo, Japan) according to the
manufacturer's instructions, following digestion of the
sample material (0.1–0.5 g) with 2 mL of a 1:2:1 mixture
of nitric acid/perchloric acid/sulfuric acid and dilution in
water to 25–125 mL [3]. MeHg and inorganic mercury in
the cellular fraction was determined using LC-ICP-MS with
a C18 reverse phase column (Atlantis dC18, 3.6×100 mm;
Waters Japan, Tokyo) following hydrochloric acid
extraction, as described previously [27]. Detection limit
was 0.0005 μg/g.
Methyl-esterified fatty acids in the serum were analyzed
using gas liquid chromatography on ShinchromE71 (Shimadzu
Co. Ltd., Kyoto) of glass column (3 mm diameter × 3 m long).
[22]. Concentrations of eicosapentaenoic acid (EPA),
docosahexaenoic acid (DHA), and other fatty acids in the
serum were determined using heptadecanoate (C17:0) as an
internal standard. The concentration of EPA plus DHA in the
serum was used in the analysis as an index of LC-PUFA.
Statistical Analysis Analysis of variance (ANOVA) and
correlation analysis were conducted using GraphPad Prism™
5.03 (GraphPad Software Inc., La Jolla, CA). Multiple
regression analysis was done using StatView (ver. 5, SAS
Institute, Cary, NC). Statistical significance level was defined
as p <0.05.
Results
To characterize the selenium compounds in the RBCs, we
determined organic selenium in the cellular fraction by a
speciation analysis method based on monitoring 82Se using
LC-ICP-MS with a GPC column (Fig. 1). The contents of
selenoneine, Se-containing proteins (including GPx,
selenoprotein P, and others), and other unidentified selenium
compounds in the cellular fraction were also determined;
selenite, selenocysteine, and selenomethionine were not
detected in the tissues examined (Table 1). Figure 1 shows
how the selenoneine in the cellular fraction was eluted at
10.1 min after the bed volume of the column. The highest
concentration of selenoneine was 2.38 μg Se selenoneine/g in
the cellular fraction (Fig. 1a). In this subject, total selenium in
the cellular fractionwas 2.40μg Se/g (Fig. 1a). In the serum of
this subject, selenoneine was below the limit of detection, and
selenium was at 0.255 μg total Se/g. In contrast, in another
subject, the lowest detected selenium concentrations in the
cellular fraction were 0.006 μg selenoneine Se/g and 0.207 μg
total Se/g, respectively, and the selenium concentration in the
serum was 0.160 μg total Se/g (Fig. 1b). Overall, the cellular
fraction contained 0.510±0.389 μg total Se/g, 0.212±
0.356 μg selenoneine Se/g, and 0.262±0.093 μg Se-
containing proteins Se/g, whereas the serum contained 0.174
±0.038 μg total Se/g.
Because we considered the range of concentrations of
selenoneine and total selenium observed in the cellular
fraction to be due to fish consumption, we compared the
concentrations of total selenium, Se-containing proteins, and
selenoneine in the cellular fraction and the levels of selenium
in the serum with the reported frequency (Fig. 2) and the
amount of fish meat per meal (Fig. 3) of fish consumption.
For all subjects, the mean concentrations of total selenium in
the cellular fraction (p -trend 0.001), selenoneine in the
cellular fraction (p -trend 0.005), Se-containing proteins in
the cellular fraction (p -trend 0.004), MeHg in the cellular
fraction (p -trend 0.008), and mercury in the serum (p -trend
0.009) increased with the frequency of fish consumption
(Fig. 2). Subjects who reported consuming fish more than
almost every day serving per week had significantly higher
concentrations of selenoneine and total selenium in their
cellular fraction than those who reported consuming fish
under every other day. In addition, concentrations of MeHg
in the cellular fraction of subjects who reported consuming
more than one or more on the 2 days serving per week were
higher than those of subjects who consumed fish under every
other day serving of fish. Concentrations of inorganic Hg in
the cellular fraction and total selenium and mercury in the
serum were not significantly related to the frequency of fish
consumption.
The amount of fish meat per meal is also closely related to
the selenium and MeHg concentration in the blood. The mean
concentrations of total selenium in the cellular fraction (p -
trend 0.001), selenoneine in the cellular fraction (p -trend
0.005), Se-containing proteins in the cellular fraction (p -trend
0.004), MeHg in the cellular fraction (p -trend 0.008), and
mercury in the serum (p -trend 0.009) increased with the
categories of amount of fish meat per meal (Fig. 3).
Concentrations of inorganic Hg in the cellular fraction and
total selenium and mercury in the serumwere not significantly
related to the amount of fish meat per meal.
We also analyzed the levels of MeHg and LC-PUFA. In the
167 subjects tested, concentrations ofMeHg ranged from 0.022
to 0.469 μg total Hg/g (mean±SD=0.087±0.076 μg/g).
Concentrations of EPA plus DHA ranged from 24 to
585 mg/kg (mean±SD=141±83 mg/kg). The content of
inorganic Hg ranged from 0.0001 to 0.0549 μg total Hg/g
(mean±SD=0.013±0.008 μg total Hg/g). Concentrations of
total mercury in the serum ranged from 0.000015 to
0.0203 μg/g (mean±SD=0.0042±0.005 μg/g).
Concentrations of selenoneine in the cellular fraction were
significantly correlated with concentrations of total selenium
(r =0.91, p <0.0001; Fig. 4a) and MeHg (r =0.58, p <
0.0001; Fig. 4b) in the cellular fraction and total selenium
(r =0.46, p <0.0001; Fig. 4c) and LC-PUFA (r =0.45, p <
0.0001; Fig. 4d) in the serum. In contrast, concentrations of
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selenoneine in the cellular fraction did not correlate
significantly with concentrations of inorganic mercury or
Se-containing proteins in the cellular fraction or levels of
total mercury in the serum. The selenium–MeHg molar ratio
in the cellular fraction ranged from 3.5:1 to 81.1:1 in all
cases examined (mean=41.9:1) (Fig. 5).
Discussion
The present study demonstrates that selenoneine is the major
selenium compound in the RBCs of a fish-eating population in
Japan. When we compared the concentrations of selenoneine




















































































Fig. 1 Speciation analysis of
organic selenium in the human
blood by LC-ICP-MS. Water-
soluble selenium compounds
were analyzed in the cellular
fraction and in the serum. a A
sample that contains a high
concentration of total selenium. b
A sample that contains a low
concentration of total selenium. c
Standards. An asterisk indicates
that Se-containing proteins
including GPx were eluted close
to the void volume of the column.
An arrow indicates the elution of
selenoneine. d , Standard curve
for selenium detection by LC-
ICP-MS. Total counts of 82Se per
min in a peak areawere accounted
for bovine GPx1 (closed circle)
and purified selenoneine (open
square)
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concentration of selenium in the serum with the frequency of
fish consumption among the 167 people living in these remote
islands, we found that levels of the selenoneine in the cellular
fraction were closely related to the frequency of fish
consumption. In the serum, we detected Se-containing
proteins and a selenosugar-like low molecular weight
compound, but not selenoneine, and concentrations of
selenium in the serum were not correlated with the frequency
of fish consumption. Therefore, selenoneine in the cellular
fraction is identified as an important biomarker of the intake
of selenium from fish consumption in this Japanese fish-eating
population.
There have been several reports on concentrations of
selenium in the blood of Japanese subjects. Imai et al. reported
that concentrations of selenium in the RBCs and serum of
middle-aged Japanese subjects were 0.244 and 0.111 μg Se/g
for males and 0.235 and 0.107 μg Se/g for females,
respectively [5]. Fish consumption, age, and alcohol intake
are related to levels of selenium in the blood. Suzuki et al.
reported that concentrations of selenium in the RBCs and
serum of Japanese female college students were 0.31 and
0.13 μg Se/g [4]. Alfthan et al. reported that supplementation
of selenium-rich yeast increased the concentration of selenium
in the plasma from 0.112 to 0.170 μg/g and the concentration
of selenium in the RBCs from 0.189 to 0.356 μg/g after
11 weeks [12]. Excessive concentrations of selenium in the
RBCs, from 0.36 to 1.32 μg/g, have been reported in residents
of a high-selenium region of Venezuela with chronic selenosis
[6]. The current findings for these remote islands in
Kagoshima show total selenium levels of 0.510 μg/g in the
Table 1 Characteristics of
subjects (n =167)
Values indicate the geometric
mean (range)
Age (years) 63.2 (29–92)
Se in the cellular fraction (μg total Se/g) 0.510 (0.099–2.99)
selenoneine in the cellular fraction (μg selenoneine Se/g) 0.212 (0.006–2.38)
Se-containing proteins in the cellular fraction (μg Se-containing proteins Se/g) 0.262 (0.087–0.777)
Se in the serum (μg total Se/g) 0.174 (0.115–0.316)
MeHg in the cellular fraction (μg total Hg/g) 0.087 (0.022–0.469)
inorganic Hg in the cellular fraction (μg total Hg/g) 0.013 (0.0001–0.0549)
Hg in the serum (μg total Hg/g) 0.0020 (0.000015–0.0203)
EPA + DHA in the serum (mg/kg) 141 (24–585)
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Fig. 2 Mean selenium andmercury concentrations of groups categorized
by frequency of fish consumption. Concentrations of total selenium,
selenoneine, and Se-containing proteins (Se protein) in the cellular
fraction, total selenium in the serum, MeHg and inorganic mercury in
the cellular fraction, and total mercury in the serum were compared to the
frequency of fish consumption. The subjects were divided into six
categories consuming fish meal: less than once per week = f-time 0, once
per week = f-time 1; two or three times per week (less than once per
2 days) = f-time 2, three or four times per week (once per 2 days) = f-time
3, everyday (five to eight times per week) = f-time 4, every time (more
than nine times per week) = f-time 5. a–g, significant differences between
the mean values (ANOVA)
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cellular fraction and 0.174 μg/g in the serum, representing the
highest exposure to selenium among previous reports on
chronic selenosis in the USA, China, Colombia, and
Venezuela. In the case of selenosis , selenite or
selenomethionine were incorporated [6]. However, the current
results indicate that the chemical form of selenium was
selenoneine derived from fish consumption, which is distinct
from the other reported cases of selenosis [6].
Recent findings from human trials have raised concern that
high long-term selenium supplementation may be associated
with type 2 diabetes or insulin resistance [28, 29]. Type 2
diabetes is associated with oxidative stress attributable to the
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Fig. 3 Mean selenium and
mercury concentrations of groups
categorized by volume of fish
consumption. Concentrations of
total selenium, selenoneine, and
Se-containing proteins (Se
protein) in the cellular fraction,
total selenium in the serum,
MeHg and inorganic mercury in
the cellular fraction, and total
mercury in the serum were
compared to the volume of fish
consumption. The subjects were
divided into five categories of the
amount of fish meat per meal:
25 g per meal = f-mass 1, 50 g per
meal = f-mass 2, 75–100 g per
meal = f-mass 3, 150 g per meal =
f-mass 4, 200 g or more per
meal = f-mass 5. a–f, significant
differences between the mean
values (ANOVA)




























































Fig. 4 Relationships between
concentrations of selenoneine and
total selenium in the cellular
fraction (a), total selenium in the
serum (b), MeHg in the cellular
fraction (c), or LC-PUFA
(EPA + DHA) (d)
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production of excess levels of reactive oxygen species in
hyperglycemia [30–32]. Selenium supplementation induces
selenoproteins, such asGPx1 and selenoprotein P [31, 32]. High
activity of GPx1 can interfere with insulin signaling by
removing hydrogen peroxide that acts as a second messenger
[30–32]. Selenoprotein P is also implicated in insulin resistance
[33]. Selenoprotein P impaired insulin signaling in the liver and
skeletal muscle in mouse and induced glucose intolerance [33].
In contrast, mice deficient in selenoprotein P showed improved
glucose tolerance and enhanced insulin signaling [33]. Selenium
yeast is predominantly selenomethionine, a form that is not
abundant in ocean fish [34]. Since long-term selenium
supplementation with selenium yeast is linked to the
development of type 2 diabetes, further research is required to
characterize whether higher selenium intake by fish and seafood
consumption may be associated with type 2 diabetes risk.
According to a recent large-scale, population-based cohort study
in Japan, fish consumption was associated with a lower risk of
type 2 diabetes in men but not in women [35]. Fish intake was
not associated with an increased risk of type 2 diabetes in either
men or women [35]. Therefore, selenoneine intake by fish
consumption might not associate with the increased risk of type
2 diabetes that found in long-term selenium supplementation
with selenium yeast.
Selenoneine is incorporated into animal cells through the
OCTN1 transporter [21]. RBCs express the OCTN1
transporter and accumulate selenoneine. The RBCs of marine
animals, such as bluefin tuna [15] and dolphins (Yamashita
et al., unpublished), contain high levels of selenoneine (>1 μg
Se/g). Anan also reported selenoneine in the liver of turtle
[36]. Klein et al. reported a selenoneine-derivative Se-
methylselenoneine in human urine [37]. Mammalian OCTN1
is thought to be involved in the secretion of cations in renal
proximal tubules and the small intestine [38]. Mutations and
variations of the OCTN1 gene and selenium status are linked
to Crohn's disease [39–41]. Further investigation will require
surveying a relationship between the susceptibility to Crohn's
disease in patients with OCTN1 variations and the dietary
selenium intake from seafood.
Previously, contents of selenium in the serum and levels of
total selenium in hair and toenail samples were measured as a
biomarker of selenium in a human population [42–46].
Plasma selenoprotein P and GPx levels were used as
biomarkers for selenium supplementation [42]. However, the
current study clearly demonstrates that the level of
selenoneine in the RBCs should be determined as a biomarker
for selenium intake and redox status by fish consumption.
Furthermore, levels of selenoneine in the cellular fraction are
closely related to levels of MeHg in the cellular fraction and
levels of LC-PUFA in the serum. Previously, mercury levels in
the cellular fraction showed a significant positive correlation
with selenium levels, suggesting that Se potentially can work to
moderate the toxicity of MeHg [47]. Blood MeHg and LC-
PUFA are also confirmed to be correlated with fish
consumption [22–25]. The selenium–MeHg molar ratio in the
cellular fraction ranged from 3.5:1 to 81.1:1 (mean=41.9:1),
suggesting that excess amounts of selenium against MeHg
contents might be present in the cellular fraction and reduce
MeHg toxicity (Fig. 5). High mercury exposure risks by fish
consumption may depend on dietary selenium intakes and
selenium status, as pointed out by Raymond et al. [18]. To
estimate the MeHg risks associated with fish consumption,
animal trials of feeding with both MeHg and selenoneine for
selenium–MeHg molar ratios of >3.5:1 in the cellular fractions
will be conducted. Selenoneine mediated MeHg demethylation
and excretion in human cultured cells and zebrafish embryos
[21]. Further study is required to obtain evidences that inorganic
mercurymight be produced by exosomal secretionmechanisms
mediated by selenoneine and OCTN1 in humans.
In conclusion, selenoneine was the major chemical form of
selenium in the cellular fraction of this fish-eating human
population. Concentrations of selenoneine and total selenium
in the cellular fraction might be used as an important
biomarker for fish consumption and selenium antioxidant
and detoxification functions.
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